Lieber Institute West Point Logo
  • ABOUT
    • ABOUT LIEBER
    • PARTNERSHIPS
    • TEAM
    • CONTACT US
  • EVENTS
  • ARTICLES OF WAR
  • LIEBER STUDIES
  • RESEARCH
  • EDUCATION
  • About
    • ABOUT ARTICLES OF WAR
    • Editorial board
    • Submission guidelines
  • Authors
  • Topics
    • Accountability
    • Conflict Types
    • Cyber
    • Detention
    • Emerging Technologies
    • Humanitarian Protection
    • Interpretation & Development
    • LOAC History
    • Space Law
    • Targeting
    • Weapons Law
    • Use of Force
  • Series
    • “Attack” Symposium
    • Justice for Syria
    • Hays Parks Symposium
    • Oxford Compliance Forum
    • Ukraine-Russia Symposium
The US Space Force at 3: Growing Dangers for a Growing Branch

The US Space Force at 3: Growing Dangers for a Growing Branch

by Jeremy Grunert | Dec 23, 2022

The US Space Force at 3: Growing Dangers for a Growing Branch On 20 December 2022, the US Space Force (USSF) will celebrate the third anniversary of its creation—an anniversary that comes at the end of a year rife with space-related challenges. The after-effects of...
Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part II

Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part II

by Robert Lawless | Dec 9, 2022

Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part II Part 1 of this post presented the factual dispute regarding Russian allegations of U.S. and Ukrainian collaboration on the development of biological weapons. It also...
Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part I

Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part I

by Robert Lawless | Dec 2, 2022

Ukraine Symposium – Russia’s Allegations of U.S. Biological Warfare in Ukraine – Part I During its invasion of Ukraine, Russia has accused the United States and Ukraine of collaborating to develop biological weapons in violation of international law. Russia’s claims...
Advisory Opinion 2.0: The Israeli-Palestinian Conflict Returns to The Hague

Advisory Opinion 2.0: The Israeli-Palestinian Conflict Returns to The Hague

by Tal Mimran, Lior Weinstein | Nov 28, 2022

Advisory Opinion 2.0: The Israeli-Palestinian Conflict Returns to The Hague The United Nations General Assembly Fourth Committee, also known as the Special Political and Decolonization Committee, addresses a range of issues, including matters relating to the...
The Legality of Intermingling Military and Civilian Capabilities in Space

The Legality of Intermingling Military and Civilian Capabilities in Space

by John Goehring | Oct 17, 2022

The Legality of Intermingling Military and Civilian Capabilities in Space The United States’ practice of intermingling national security space functions with commercial space capabilities and services has come under fire. Professor David Koplow, in an article entitled...
Deficiencies and Ambiguities of the Treaty on the Prohibition of Nuclear Weapons

Deficiencies and Ambiguities of the Treaty on the Prohibition of Nuclear Weapons

by Bakhtiyar Tuzmukhamedov | Sep 30, 2022

Deficiencies and Ambiguities of the Treaty on the Prohibition of Nuclear Weapons Touted as an effort to “reframe the debate on nuclear weapons,” the Treaty on the Prohibition of Nuclear Weapons (TPNW) has currently accumulated 66 ratifications, a little over a year...
« Older Entries

lieber institute

MADN-LAW
United States Military Academy 

646 Swift Road
West Point, NY 10996

+1-845-938-2572

Articles of War Disclaimer

The views expressed are those of the authors, and do not necessarily reflect the official position of the United States Military Academy, Department of the Army, or Department of Defense. 

Articles of War is a forum for professionals to share opinions and cultivate ideas. Articles of War does not screen articles to fit a particular editorial agenda, nor endorse or advocate material that is published.

west point logo

Connect

  • Follow
  • Follow
email
 Twitter
 Facebook
 LinkedIn
 Copy
 Email